Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul-Sep;13(3):126-131.
doi: 10.14797/mdcj-13-3-126.

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Affiliations
Review

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Manuel Reyes et al. Methodist Debakey Cardiovasc J. 2017 Jul-Sep.

Abstract

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Keywords: SAVR; TAVR; expandable valve; surgical aortic valve replacement; transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: The authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported.

Figures

Figure 1.
Figure 1.
The decrease in 12-month moderate-to-severe paravalvular leak in transcatheter aortic valve replacement in less than a decade.,,,,

References

    1. Ross J Jr, Braunwald E.. Aortic stenosis. Circulation. 1968. July; 38 1 Suppl: 61– 7. - PubMed
    1. Nishimura RA, Otto CM, Bonow RO, . et al. . ;American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014. June 10; 63 22: e57– 185. - PubMed
    1. Vahanian A, Alfieri O, Andreotti F, . et al. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome). 2013. March; 14 3: 167– 214. - PubMed
    1. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK.. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009. November; 2 6: 533– 9. - PubMed
    1. Cribier A, Eltchaninoff H, Bash A, . et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002. December 10; 106 24: 3006– 8. - PubMed

MeSH terms

LinkOut - more resources